newsfilter
← Latest News
GlobeNewswire·

SpringWorks Therapeutics Appoints Dr. Martin Mackay to its Board of Directors

STAMFORD, Conn., July 29, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced the appointment